Skip to main content
PMC home page
American Journal of Human Genetics logoLink to American Journal of Human Genetics
. 1997 Jul;61(1):171–181. doi: 10.1086/513902

Evidence that the apolipoprotein E-genotype effects on lipid levels can change with age in males: a longitudinal analysis.

G P Jarvik 1, E L Goode 1, M A Austin 1, J Auwerx 1, S Deeb 1, G D Schellenberg 1, T Reed 1
PMCID: PMC1715863  PMID: 9245998

Abstract

We previously reported that change, with age, in plasma levels of total cholesterol (TC) and LDL cholesterol (LDL-C) differed between apolipoprotein E (APOE) genotypes epsilon 3 epsilon 3 and epsilon 3 epsilon 4, in a sample of 77 older, unrelated males. By use of a larger sample from that cohort, followed longitudinally during 1969-87, the change in TC and in LDL-C, between the epsilon 3 epsilon 3 and epsilon 3 epsilon 4 APOE genotypes, over three exams, was reanalyzed. Additionally, the change in triglycerides (TG) and in HDL-cholesterol (HDL-C), between the epsilon 3 epsilon 3 and epsilon 3 epsilon 4 APOE genotypes-as well as the differences between the epsilon 3 epsilon 3 and epsilon 3 epsilon 2 genotypes, for TC, LDL-C, TG, and HDL-C-were contrasted over the three exams. At exam 1 TG was higher in the epsilon 3 epsilon 4 group than in the epsilon 3 epsilon 3 group (mean age 48 years), and at exams 2 and exam 3 (mean ages 58 and 63 years, respectively) it was similar (P = .009 for the exam-by-genotype-interaction effect in the repeated-measures analysis). A similar trend was seen for TC (P = .03), yet previously detected LDL-C effects were not apparent (P = .46). Those with the epsilon 3 epsilon 2 genotype had higher TG and lower LDL-C and TC at each exam than were seen in those with the epsilon 3 epsilon 3 genotype, although the differences in the values were not always statistically significant. Differences in TC, LDL-C, and TG, between the epsilon 3 epsilon 2-genotype and epsilon 3 epsilon 3-genotype groups, did not significantly change over the three exams. HDL-C levels were relatively stable over the exams; however, the exam-by-genotype interaction was significant for the epsilon 3 epsilon 2 genotype versus the epsilon 3 epsilon 3 genotype (P = .02). The epsilon 4 allele effects on TG and TC changed between longitudinal exams and may be age dependent. Changes, with age, in the effect of the epsilon 3 epsilon 4 genotype on lipids may impact the risk of developing atherosclerotic disease.

Full text

PDF
171

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Allain C. C., Poon L. S., Chan C. S., Richmond W., Fu P. C. Enzymatic determination of total serum cholesterol. Clin Chem. 1974 Apr;20(4):470–475. [PubMed] [Google Scholar]
  2. Alvarez C., Orejas A., Gonzalez S., Diaz R., Colomo L. F. Reference intervals for serum lipids, lipoproteins, and apoproteins in the elderly. Clin Chem. 1984 Mar;30(3):404–406. [PubMed] [Google Scholar]
  3. Boerwinkle E., Sing C. F. The use of measured genotype information in the analysis of quantitative phenotypes in man. III. Simultaneous estimation of the frequencies and effects of the apolipoprotein E polymorphism and residual polygenetic effects on cholesterol, betalipoprotein and triglyceride levels. Ann Hum Genet. 1987 Jul;51(Pt 3):211–226. doi: 10.1111/j.1469-1809.1987.tb00874.x. [DOI] [PubMed] [Google Scholar]
  4. Boerwinkle E., Utermann G. Simultaneous effects of the apolipoprotein E polymorphism on apolipoprotein E, apolipoprotein B, and cholesterol metabolism. Am J Hum Genet. 1988 Jan;42(1):104–112. [PMC free article] [PubMed] [Google Scholar]
  5. Cauley J. A., Eichner J. E., Kamboh M. I., Ferrell R. E., Kuller L. H. Apo E allele frequencies in younger (age 42-50) vs older (age 65-90) women. Genet Epidemiol. 1993;10(1):27–34. doi: 10.1002/gepi.1370100104. [DOI] [PubMed] [Google Scholar]
  6. Christian J. C., Borhani N. O., Castelli W. P., Fabsitz R., Norton J. A., Jr, Reed T., Rosenman R., Wood P. D., Yu P. L. Plasma cholesterol variation in the National Heart, Lung and Blood Institute Twin Study. Genet Epidemiol. 1987;4(6):433–446. doi: 10.1002/gepi.1370040605. [DOI] [PubMed] [Google Scholar]
  7. Christian J. C., Carmelli D., Castelli W. P., Fabsitz R., Grim C. E., Meaney F. J., Norton J. A., Jr, Reed T., Williams C. J., Wood P. D. High density lipoprotein cholesterol. A 16-year longitudinal study in aging male twins. Arteriosclerosis. 1990 Nov-Dec;10(6):1020–1025. doi: 10.1161/01.atv.10.6.1020. [DOI] [PubMed] [Google Scholar]
  8. Christian J. C., Feinleib M., Hulley S. B., Castelli W. P., Fabsitz R. R., Garrison R. J., Borhani N. O., Rosenman R. H., Wagner J. Genetics of plasma cholesterol and triglycerides: a study of adult male twins. Acta Genet Med Gemellol (Roma) 1976;25:145–149. doi: 10.1017/s000156600001401x. [DOI] [PubMed] [Google Scholar]
  9. Corder E. H., Saunders A. M., Strittmatter W. J., Schmechel D. E., Gaskell P. C., Small G. W., Roses A. D., Haines J. L., Pericak-Vance M. A. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science. 1993 Aug 13;261(5123):921–923. doi: 10.1126/science.8346443. [DOI] [PubMed] [Google Scholar]
  10. Cumming A. M., Robertson F. W. Genetics of the apolipoprotein-E isoprotein system in man. J Med Genet. 1982 Dec;19(6):417–423. doi: 10.1136/jmg.19.6.417. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Dallongeville J., Lussier-Cacan S., Davignon J. Modulation of plasma triglyceride levels by apoE phenotype: a meta-analysis. J Lipid Res. 1992 Apr;33(4):447–454. [PubMed] [Google Scholar]
  12. Davignon J., Bouthillier D., Nestruck A. C., Sing C. F. Apolipoprotein E polymorphism and atherosclerosis: insight from a study in octogenarians. Trans Am Clin Climatol Assoc. 1988;99:100–110. [PMC free article] [PubMed] [Google Scholar]
  13. Davignon J., Gregg R. E., Sing C. F. Apolipoprotein E polymorphism and atherosclerosis. Arteriosclerosis. 1988 Jan-Feb;8(1):1–21. doi: 10.1161/01.atv.8.1.1. [DOI] [PubMed] [Google Scholar]
  14. Demant T., Bedford D., Packard C. J., Shepherd J. Influence of apolipoprotein E polymorphism on apolipoprotein B-100 metabolism in normolipemic subjects. J Clin Invest. 1991 Nov;88(5):1490–1501. doi: 10.1172/JCI115459. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Feinleib M., Garrison R. J., Fabsitz R., Christian J. C., Hrubec Z., Borhani N. O., Kannel W. B., Rosenman R., Schwartz J. T., Wagner J. O. The NHLBI twin study of cardiovascular disease risk factors: methodology and summary of results. Am J Epidemiol. 1977 Oct;106(4):284–285. doi: 10.1093/oxfordjournals.aje.a112464. [DOI] [PubMed] [Google Scholar]
  16. Friedewald W. T., Levy R. I., Fredrickson D. S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972 Jun;18(6):499–502. [PubMed] [Google Scholar]
  17. Gregg R. E., Zech L. A., Schaefer E. J., Stark D., Wilson D., Brewer H. B., Jr Abnormal in vivo metabolism of apolipoprotein E4 in humans. J Clin Invest. 1986 Sep;78(3):815–821. doi: 10.1172/JCI112645. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Gueguen R., Visvikis S., Steinmetz J., Siest G., Boerwinkle E. An analysis of genotype effects and their interactions by using the apolipoprotein E polymorphism and longitudinal data. Am J Hum Genet. 1989 Nov;45(5):793–802. [PMC free article] [PubMed] [Google Scholar]
  19. Hershcopf R. J., Elahi D., Andres R., Baldwin H. L., Raizes G. S., Schocken D. D., Tobin J. D. Longitudinal changes in serum cholesterol in man: an epidemiologic search for an etiology. J Chronic Dis. 1982 Feb;35(2):101–114. doi: 10.1016/0021-9681(82)90111-4. [DOI] [PubMed] [Google Scholar]
  20. Hixson J. E., Vernier D. T. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. J Lipid Res. 1990 Mar;31(3):545–548. [PubMed] [Google Scholar]
  21. Jarvik G. P., Austin M. A., Fabsitz R. R., Auwerx J., Reed T., Christian J. C., Deeb S. Genetic influences on age-related change in total cholesterol, low density lipoprotein-cholesterol, and triglyceride levels: longitudinal apolipoprotein E genotype effects. Genet Epidemiol. 1994;11(4):375–384. doi: 10.1002/gepi.1370110407. [DOI] [PubMed] [Google Scholar]
  22. Jarvik G. P., Wijsman E. M., Kukull W. A., Schellenberg G. D., Yu C., Larson E. B. Interactions of apolipoprotein E genotype, total cholesterol level, age, and sex in prediction of Alzheimer's disease: a case-control study. Neurology. 1995 Jun;45(6):1092–1096. doi: 10.1212/wnl.45.6.1092. [DOI] [PubMed] [Google Scholar]
  23. Jenkins D. J., Hegele R. A., Jenkins A. L., Connelly P. W., Hallak K., Bracci P., Kashtan H., Corey P., Pintilia M., Stern H. The apolipoprotein E gene and the serum low-density lipoprotein cholesterol response to dietary fiber. Metabolism. 1993 May;42(5):585–593. doi: 10.1016/0026-0495(93)90217-c. [DOI] [PubMed] [Google Scholar]
  24. Kuusi T., Nieminen M. S., Ehnholm C., Yki-Järvinen H., Valle M., Nikkilä E. A., Taskinen M. R. Apoprotein E polymorphism and coronary artery disease. Increased prevalence of apolipoprotein E-4 in angiographically verified coronary patients. Arteriosclerosis. 1989 Mar-Apr;9(2):237–241. doi: 10.1161/01.atv.9.2.237. [DOI] [PubMed] [Google Scholar]
  25. Lehtimäki T., Moilanen T., Solakivi T., Laippala P., Ehnholm C. Cholesterol-rich diet induced changes in plasma lipids in relation to apolipoprotein E phenotype in healthy students. Ann Med. 1992 Feb;24(1):61–66. doi: 10.3109/07853899209164146. [DOI] [PubMed] [Google Scholar]
  26. Lenzen H. J., Assmann G., Buchwalsky R., Schulte H. Association of apolipoprotein E polymorphism, low-density lipoprotein cholesterol, and coronary artery disease. Clin Chem. 1986 May;32(5):778–781. [PubMed] [Google Scholar]
  27. Lopez-Miranda J., Ordovas J. M., Mata P., Lichtenstein A. H., Clevidence B., Judd J. T., Schaefer E. J. Effect of apolipoprotein E phenotype on diet-induced lowering of plasma low density lipoprotein cholesterol. J Lipid Res. 1994 Nov;35(11):1965–1975. [PubMed] [Google Scholar]
  28. Mahley R. W. Apolipoprotein E and cholesterol metabolism. Klin Wochenschr. 1983 Mar 1;61(5):225–232. doi: 10.1007/BF01496128. [DOI] [PubMed] [Google Scholar]
  29. Menzel H. J., Kladetzky R. G., Assmann G. Apolipoprotein E polymorphism and coronary artery disease. Arteriosclerosis. 1983 Jul-Aug;3(4):310–315. doi: 10.1161/01.atv.3.4.310. [DOI] [PubMed] [Google Scholar]
  30. Newschaffer C. J., Bush T. L., Hale W. E. Aging and total cholesterol levels: cohort, period, and survivorship effects. Am J Epidemiol. 1992 Jul 1;136(1):23–34. doi: 10.1093/oxfordjournals.aje.a116417. [DOI] [PubMed] [Google Scholar]
  31. Reardon M. F., Nestel P. J., Craig I. H., Harper R. W. Lipoprotein predictors of the severity of coronary artery disease in men and women. Circulation. 1985 May;71(5):881–888. doi: 10.1161/01.cir.71.5.881. [DOI] [PubMed] [Google Scholar]
  32. Reed T., Carmelli D., Christian J. C., Selby J. V., Fabsitz R. R. The NHLBI male veteran twin study data. Genet Epidemiol. 1993;10(6):513–517. doi: 10.1002/gepi.1370100630. [DOI] [PubMed] [Google Scholar]
  33. Reed T., Quiroga J., Selby J. V., Carmelli D., Christian J. C., Fabsitz R. R., Grim C. E. Concordance of ischemic heart disease in the NHLBI twin study after 14-18 years of follow-up. J Clin Epidemiol. 1991;44(8):797–805. doi: 10.1016/0895-4356(91)90132-s. [DOI] [PubMed] [Google Scholar]
  34. Reilly S. L., Ferrell R. E., Kottke B. A., Sing C. F. The gender-specific apolipoprotein E genotype influence on the distribution of plasma lipids and apolipoproteins in the population of Rochester, Minnesota. II. Regression relationships with concomitants. Am J Hum Genet. 1992 Dec;51(6):1311–1324. [PMC free article] [PubMed] [Google Scholar]
  35. Sampson E. J., Demers L. M., Krieg A. F. Faster enzymatic procedure for serum triglycerides. Clin Chem. 1975 Dec;21(13):1983–1985. [PubMed] [Google Scholar]
  36. Schächter F., Faure-Delanef L., Guénot F., Rouger H., Froguel P., Lesueur-Ginot L., Cohen D. Genetic associations with human longevity at the APOE and ACE loci. Nat Genet. 1994 Jan;6(1):29–32. doi: 10.1038/ng0194-29. [DOI] [PubMed] [Google Scholar]
  37. Selby J. V., Reed T., Newman B., Fabsitz R. R., Carmelli D. Effects of selective return on estimates of heritability for body mass index in the National Heart, Lung, and Blood Institute Twin Study. Genet Epidemiol. 1991;8(6):371–380. doi: 10.1002/gepi.1370080603. [DOI] [PubMed] [Google Scholar]
  38. Sheeber L. B., Sorensen E. D., Howe S. R. Data analytic techniques for treatment outcome studies with pretest/posttest measurements: an extensive primer. J Psychiatr Res. 1996 May-Jun;30(3):185–199. doi: 10.1016/0022-3956(96)00012-X. [DOI] [PubMed] [Google Scholar]
  39. Sing C. F., Davignon J. Role of the apolipoprotein E polymorphism in determining normal plasma lipid and lipoprotein variation. Am J Hum Genet. 1985 Mar;37(2):268–285. [PMC free article] [PubMed] [Google Scholar]
  40. Uusitupa M. I., Ruuskanen E., Mäkinen E., Laitinen J., Toskala E., Kervinen K., Kesäniemi Y. A. A controlled study on the effect of beta-glucan-rich oat bran on serum lipids in hypercholesterolemic subjects: relation to apolipoprotein E phenotype. J Am Coll Nutr. 1992 Dec;11(6):651–659. doi: 10.1080/07315724.1992.10718264. [DOI] [PubMed] [Google Scholar]
  41. Warnick G. R., Knopp R. H., Fitzpatrick V., Branson L. Estimating low-density lipoprotein cholesterol by the Friedewald equation is adequate for classifying patients on the basis of nationally recommended cutpoints. Clin Chem. 1990 Jan;36(1):15–19. [PubMed] [Google Scholar]
  42. Wilson P. W., Myers R. H., Larson M. G., Ordovas J. M., Wolf P. A., Schaefer E. J. Apolipoprotein E alleles, dyslipidemia, and coronary heart disease. The Framingham Offspring Study. JAMA. 1994 Dec 7;272(21):1666–1671. [PubMed] [Google Scholar]
  43. Yu C. E., Payami H., Olson J. M., Boehnke M., Wijsman E. M., Orr H. T., Kukull W. A., Goddard K. A., Nemens E., White J. A. The apolipoprotein E/CI/CII gene cluster and late-onset Alzheimer disease. Am J Hum Genet. 1994 Apr;54(4):631–642. [PMC free article] [PubMed] [Google Scholar]
  44. Zannis V. I., Just P. W., Breslow J. L. Human apolipoprotein E isoprotein subclasses are genetically determined. Am J Hum Genet. 1981 Jan;33(1):11–24. [PMC free article] [PubMed] [Google Scholar]
  45. Zerba K. E., Ferrell R. E., Sing C. F. Genotype-environment interaction: apolipoprotein E (ApoE) gene effects and age as an index of time and spatial context in the human. Genetics. 1996 May;143(1):463–478. doi: 10.1093/genetics/143.1.463. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from American Journal of Human Genetics are provided here courtesy of American Society of Human Genetics

RESOURCES